Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active ingredient etanercept (ATC code according to WHO: L04AB01

AOK PLUS - DIE GESUNDHEITSKASSE FUR SACHSEN UND THURINGEN Germany has Released a tender for Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active ingredient etanercept (ATC code according to WHO: L04AB01 in Pharmaceuticals. The tender was released on Jan 25, 2023.

Country - Germany

Summary - Conclusion of non-exclusive drug discount agreements according to § 130a Para. 8 SGB V by means of a so-called open house model for the active ingredient etanercept (ATC code according to WHO: L04AB01

Deadline - Mar 31, 2025

MT reference number - 11296889

Product classification - Medical solutions

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 11296889

  Document Type - Tender Notices

Notice Details and Documents:

Description - Contract notice: conclusion of non-exclusive drug discount agreements according to § 130a para. 8 sgb v by way of a so-called open-house model for the active ingredient etanercept (atc code according to who: l04ab01)The subject of this publication i s the conclusion of non-exclusive discount agreements according to § 130a para. 8 sgb v on drugs with the active ingredient etanercept (atc code according to who: l04ab01). the contract is concluded as part of a so-called open-house model, i. h. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. as a result, individual contract negotiations

Mt Ref Id - 11296889

Deadline - Mar 31, 2025

Share

Similar Tenders :